TGA1 Antibody

What is TGA1 and what is its function in plants?

TGA1 is a transcription factor belonging to the family of TGACG-binding factors that plays a significant role in plant immune responses. TGA1 can act in the NPR1- and SA-dependent signaling cascade, which is crucial for plant defense mechanisms . It contains redox-active cysteines that were previously thought to regulate its function through a redox switch mechanism, although recent research has questioned the functional significance of this mechanism . TGA factors form a family of ten members which are grouped into five clades, with TGA1 having both overlapping and distinct functions from other family members such as the clade-II TGAs (TGA2, TGA5, and TGA6) which function together with NPR1 in systemic acquired resistance . Research has shown that TGA1 regulates a specific subset of defense-related genes, with studies identifying 45 SA-induced NPR1-dependent genes that are regulated by TGA1/TGA4 .

How is TGA1 antibody typically generated for research purposes?

TGA1 antibody is typically generated using the C-terminal region of the TGA1 protein. According to published research, an antibody was successfully generated using the TGA1 C-terminal protein and was used for Western blot analysis as part of the initial characterization of the tga1 gene . The process generally involves expressing and purifying recombinant TGA1 C-terminal protein, followed by immunization in appropriate host animals to generate polyclonal antibodies. For monoclonal antibody production, additional steps involving hybridoma technology would be required. The specificity of the antibody to TGA1 is crucial, particularly when studying its function in relation to other closely related TGA family members, which necessitates careful epitope selection during antibody development.

Why is TGA1 an important research target in plant biology?

TGA1 represents an important research target in plant biology due to its central role in immune response regulation and developmental processes. Studies have demonstrated that TGA1 functions in both NPR1-dependent and independent pathways, with the tga1 tga4 double mutant showing increased susceptibility to pathogens . Research has also revealed TGA1's significance beyond immunity - in maize, fine mapping demonstrated that a causal polymorphism distinguishing maize and teosinte lies within a 1042-bp segment of tga1, indicating its importance in crop domestication . The redox-active cysteines in TGA1 have been extensively studied, with some research suggesting these modifications may not affect function as previously thought . This evolving understanding makes TGA1 a fascinating target for researchers exploring plant signaling networks, stress responses, and evolutionary adaptations in crop plants.

What are the optimal protocols for using TGA1 antibody in Western blot analysis?

For optimal Western blot analysis with TGA1 antibody, researchers should follow several critical steps to ensure specific detection. Begin sample preparation by extracting plant proteins using a buffer containing protease inhibitors to prevent degradation of the target protein. The redox status of TGA1 is an important consideration, as the protein contains redox-active cysteines that may affect antibody recognition . Therefore, consider parallel extractions under both reducing and non-reducing conditions.

For protein separation, use 10-12% SDS-PAGE gels and load 20-50 μg of total protein per lane. After transfer to a PVDF membrane, block thoroughly with 5% non-fat dry milk in TBST to minimize background. Primary TGA1 antibody incubation should be performed overnight at 4°C at an optimized dilution (typically starting with 1:1000 to 1:3000). For detection, use appropriate HRP-conjugated secondary antibodies and ECL substrate.

When analyzing results, be aware that TGA1 is expressed at relatively low levels as a transcription factor, and its detection may require enhanced sensitivity methods. Additionally, observed band patterns should be validated with appropriate controls, such as samples from tga1 knockout plants, to confirm specificity .

How can TGA1 antibody be used in chromatin immunoprecipitation (ChIP) experiments?

Chromatin immunoprecipitation with TGA1 antibody allows researchers to identify genomic binding sites of this transcription factor. For effective ChIP experiments, begin by cross-linking plant material with 1% formaldehyde for 10-15 minutes to preserve protein-DNA interactions. After quenching with glycine, extract and sonicate chromatin to obtain fragments of approximately 200-500 bp.

Pre-clear the chromatin preparation with Protein A/G beads before immunoprecipitation with TGA1 antibody. Include appropriate controls, such as IgG and input samples. When working with TGA1, special consideration should be given to its redox state, as this may affect DNA binding activity. Studies have questioned the previously established model of the TGA1 redox switch affecting DNA binding , but experimental conditions should still account for potential redox sensitivity.

For analysis of immunoprecipitated DNA, qPCR targeting promoter regions of known or suspected TGA1 target genes is recommended. Focus particularly on promoters containing the TGACG motif, which is recognized by TGA family proteins. For genome-wide binding analysis, ChIP followed by next-generation sequencing (ChIP-seq) provides comprehensive binding profiles. This approach can help resolve questions about TGA1's role in regulating the 45 SA-induced NPR1-dependent genes identified in previous research .

What approaches are effective for studying TGA1 protein-protein interactions?

To investigate TGA1 protein-protein interactions, co-immunoprecipitation (co-IP) with TGA1 antibody represents a powerful approach. Extract plant tissues using non-denaturing buffers that preserve protein complexes, typically containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40, and protease inhibitors. The redox conditions during extraction are particularly important when studying TGA1 interactions, as previous research has suggested that reduction of TGA1's cysteine residues affects its interaction with NPR1 .

Incubate protein extracts with TGA1 antibody, followed by capture with Protein A/G beads. After washing, analyze the immunoprecipitated complexes by SDS-PAGE and Western blotting to detect interacting partners. When studying TGA1-NPR1 interactions specifically, antibodies against NPR1 should be used for detection of co-immunoprecipitated proteins.

Other complementary approaches include yeast two-hybrid assays for initial screening of interactions, bimolecular fluorescence complementation for in vivo visualization, and mass spectrometry analysis of immunoprecipitated complexes for unbiased identification of interaction partners. The latter approach is particularly valuable for identifying novel TGA1 interactors beyond the well-established NPR1 interaction. Research has shown conflicting data regarding TGA1's interaction partners and their functional significance , making careful experimental design and controls essential for reliable results.

What are common issues encountered when using TGA1 antibody and how can they be resolved?

Researchers working with TGA1 antibody commonly encounter several technical challenges. Weak or no signal is a frequent problem, potentially due to low TGA1 expression levels in plant tissues. This can be addressed by increasing protein loading, optimizing antibody concentration, extending incubation times, or using more sensitive detection systems. Additionally, enrichment through nuclear fraction isolation may improve detection, as TGA1 is a nuclear-localized transcription factor.

Non-specific binding represents another common issue, resulting in multiple bands on Western blots. This can be minimized by increasing blocking time, using more stringent washing conditions, or pre-absorbing the antibody with non-specific proteins. When working with TGA1, cross-reactivity with other TGA family members is a particular concern given their sequence similarity. Validation using tga1 knockout/knockdown plants as negative controls is essential to confirm specificity .

High background is often encountered and can be reduced by optimizing antibody dilutions, increasing wash stringency, and ensuring complete blocking. For immunoprecipitation experiments, successful TGA1 pull-down may be complicated by its relatively low abundance and potential interaction with other proteins that might mask epitopes. In these cases, crosslinking approaches or altered extraction conditions may improve results. Researchers should also be aware that TGA1's redox-sensitive cysteines might affect antibody recognition depending on extraction conditions .

How can researchers validate the specificity of their TGA1 antibody?

Validating TGA1 antibody specificity is crucial for reliable experimental outcomes. Multiple complementary approaches should be employed for comprehensive validation. First, comparison of wild-type plants with tga1 knockout or knockdown lines provides the most definitive control. The absence or significant reduction of the target band in Western blots from knockout/knockdown samples strongly supports antibody specificity .

Peptide competition assays offer another validation strategy. Pre-incubating the antibody with excess synthetic peptide corresponding to the immunization epitope should abolish specific binding in Western blots. For cross-reactivity assessment, testing the antibody against recombinant proteins of closely related TGA family members is advisable, particularly TGA4 which shares high sequence homology with TGA1.

Immunoprecipitation followed by mass spectrometry analysis can provide unbiased confirmation of antibody specificity by identifying the proteins captured by the antibody. The predominant presence of TGA1 in immunoprecipitates would support specificity. Additionally, comparing results obtained with different TGA1 antibodies raised against distinct epitopes can increase confidence in observed patterns. Researchers should be particularly careful when working with TGA1 in different plant species, as sequence variations may affect antibody recognition despite functional conservation of the protein .

What factors affect TGA1 protein stability and detection in experimental samples?

Multiple factors influence TGA1 stability and detection in experimental samples. The redox status of the protein significantly impacts its conformation due to the presence of redox-active cysteines that can form disulfide bonds . Extraction buffers containing reducing agents like DTT or β-mercaptoethanol can break these bonds, potentially altering epitope accessibility and antibody recognition. Studies on TGA1 have questioned the functional significance of its redox regulation, with research showing that a TGA1 quadruple Cys mutant (mimicking the reduced form) showed similar activity to wild-type TGA1 .

Post-translational modifications beyond redox changes may affect TGA1 detection. While specific information on TGA1 phosphorylation, SUMOylation or ubiquitination is limited in the provided search results, these modifications commonly regulate transcription factor activity and stability. The presence of protease inhibitors during extraction is essential to prevent degradation, particularly for low-abundance transcription factors like TGA1.

Experimental treatments can dramatically alter TGA1 levels and modifications. Salicylic acid treatment, pathogen infection, and other stress conditions modulate TGA1 activity and potentially its detectability. For instance, research has examined TGA1's role in NPR1-dependent and independent pathways during immune responses . Additionally, tissue-specific and developmental regulation of TGA1 expression necessitates careful consideration of sample selection when comparing experimental conditions.

How should researchers interpret conflicting results with TGA1 antibody across different experimental conditions?

Interpreting conflicting results with TGA1 antibody requires careful consideration of several factors. First, differences in redox conditions during sample preparation can significantly affect TGA1 detection. The protein contains redox-active cysteines that influence its conformation and potentially antibody recognition . Researchers should compare extraction methods, noting whether reducing agents were included, and consider performing parallel experiments under both reducing and non-reducing conditions.

Different antibodies may recognize distinct epitopes on TGA1, leading to divergent results. Some antibodies might preferentially detect certain post-translationally modified forms or conformational states of TGA1. For instance, research has questioned the functional significance of TGA1's redox switch, with findings showing that a TGA1 quadruple Cys mutant (mimicking the reduced form) displayed similar activity to wild-type TGA1 . This suggests that apparent differences in TGA1 detection might reflect altered epitope accessibility rather than changes in protein levels.

Experimental context is crucial for interpretation. TGA1's activity changes during immune responses, with different roles in NPR1-dependent and independent pathways . Timing of sample collection relative to stimulus application (e.g., pathogen infection or salicylic acid treatment) can dramatically influence results. Additionally, TGA1 function varies across tissues and developmental stages, making direct comparisons between dissimilar samples problematic. When conflicting results persist despite controlling these variables, researchers should consider employing complementary techniques such as RNA analysis, functional assays, or alternative antibodies targeting different epitopes.

What does the current research reveal about TGA1's redox regulation and its implications for antibody-based studies?

Studies have shown that a TGA1 quadruple cysteine mutant, which presumably mimics the reduced and supposedly active form of TGA1, does not induce marker genes to a greater extent than the wild-type protein . This suggests that the redox switch may not be as critical for TGA1 function as previously thought. The quadruple mutant is believed to adopt a conformation compatible with NPR1 interaction, analogous to reduced wild-type TGA1 where disulfide linkages have been broken .

For antibody-based studies, these findings have several implications. Antibodies generated against specific conformations of TGA1 might show differential binding depending on redox conditions during sample preparation. Researchers should be cautious when interpreting changes in TGA1 detection, as these might reflect alterations in epitope accessibility rather than actual protein level changes. Furthermore, the functional significance of observed redox changes should be evaluated critically rather than assuming they directly regulate TGA1 activity. When designing experiments, parallel analyses under different redox conditions and inclusion of TGA1 cysteine mutants as controls can help distinguish between redox-dependent epitope recognition and biologically meaningful redox regulation .

How can researchers differentiate between true biological changes in TGA1 and technical artifacts in antibody-based experiments?

Differentiating true biological changes in TGA1 from technical artifacts requires systematic control strategies and complementary approaches. First, researchers should include appropriate positive and negative controls in every experiment. Recombinant TGA1 protein serves as a positive control, while samples from tga1 knockout plants provide essential negative controls . For suspected post-translational modifications, controls might include treatment with specific modifying or demodifying enzymes (phosphatases, deubiquitinases, etc.) to confirm band shifts represent the modifications of interest.

Technical replication with consistent results significantly increases confidence in observed patterns. When possible, biological validation through alternative methods is invaluable - for example, confirming antibody-detected changes in TGA1 protein levels with corresponding changes in functional readouts like target gene expression. Complementary approaches such as mass spectrometry can provide unbiased confirmation of TGA1 modifications detected by antibodies.

Titration experiments can help distinguish specific from non-specific signals. True TGA1 bands should show concentration-dependent changes with varying sample amounts, while non-specific bands may not follow the same pattern. When exploring TGA1's redox regulation, parallel analysis under reducing and non-reducing conditions can reveal whether observed changes relate to redox-dependent epitope accessibility or actual protein abundance differences . For studies examining TGA1-NPR1 interactions, which have been proposed to be redox-regulated, co-immunoprecipitation experiments under controlled redox conditions with appropriate controls can help distinguish true interaction dynamics from artifacts .

How can TGA1 antibody be used to investigate the role of TGA1 in plant immune responses?

TGA1 antibody provides powerful tools for investigating TGA1's roles in plant immunity. Through chromatin immunoprecipitation (ChIP) experiments, researchers can map TGA1 binding sites across the genome before and after immune activation. This approach can help resolve conflicting data regarding TGA1's role in regulating the 45 SA-induced NPR1-dependent genes identified in previous research . By comparing binding profiles in wild-type plants versus immune-signaling mutants (e.g., npr1), researchers can distinguish between NPR1-dependent and independent functions of TGA1.

Co-immunoprecipitation with TGA1 antibody followed by mass spectrometry analysis enables identification of TGA1 interaction partners during different phases of immune responses. This unbiased approach may reveal previously unknown interactions beyond the well-characterized TGA1-NPR1 association . Researchers should pay particular attention to redox conditions during sample preparation, as these may affect TGA1 interactions, though recent research has questioned the functional significance of TGA1's redox regulation .

Immunoblot analysis with TGA1 antibody can track changes in TGA1 abundance, localization, and post-translational modifications during immune responses. Though research suggests TGA1 transcript levels may not change significantly between certain genotypes (e.g., maize and teosinte alleles) , protein-level regulation might be more dynamic. For tissue-specific analysis, immunohistochemistry with TGA1 antibody can reveal spatiotemporal patterns of expression during immune responses, potentially uncovering tissue-specific functions not apparent in whole-plant studies.

What approaches can be used to study evolutionary aspects of TGA1 function across plant species?

Studying evolutionary aspects of TGA1 function across plant species requires carefully designed comparative approaches using TGA1 antibody and complementary techniques. Sequence alignment analysis should first determine epitope conservation in TGA1 orthologs across target species. Western blot analysis can then compare TGA1 protein expression patterns across species, with recombinant TGA1 proteins from each species serving as controls to calibrate detection sensitivity. This approach can reveal evolutionary conservation or divergence in TGA1 regulation at the protein level, complementing transcript-based studies.

Research has already demonstrated TGA1's evolutionary significance, with evidence that a causal polymorphism distinguishing maize and teosinte lies within a 1042-bp segment of tga1 . Intriguingly, RT-qPCR analysis showed no statistical difference in message accumulation between maize and teosinte alleles of tga1, suggesting post-transcriptional regulation differences . TGA1 antibody can help investigate whether such differences manifest at the protein level through comparative immunoblot analysis of TGA1 protein abundance, stability, and post-translational modifications.

For functional conservation studies, ChIP experiments with TGA1 antibody across species can compare genome-wide binding profiles, revealing evolution of regulatory networks. Co-immunoprecipitation studies can identify species-specific interaction partners, potentially explaining functional diversification. When antibody cross-reactivity between species is limited, generating species-specific antibodies against conserved epitopes may be necessary. Alternatively, epitope tagging of TGA1 in different species followed by tag-specific antibody detection provides a standardized detection method, though potential functional interference from tags must be considered.

How can researchers use TGA1 antibody to study the relationship between TGA1 and other TGA family members?

Investigating relationships between TGA1 and other TGA family members requires careful antibody selection and experimental design. When using TGA1 antibody, researchers must first establish its specificity among TGA family members through Western blot analysis of recombinant TGA proteins and samples from single and higher-order tga mutants. If cross-reactivity exists, epitope mapping can identify TGA1-specific regions for generating more selective antibodies. Alternatively, immunodepletion strategies can be employed, where sequential immunoprecipitation with antibodies against different TGA factors clarifies their distinct functions.

For studying functional redundancy or cooperation between TGA1 and other family members, ChIP experiments with specific antibodies against different TGA factors can compare their genome-wide binding profiles. Overlapping binding sites suggest redundant functions, while unique targets indicate specialized roles. Research has shown different functions between TGA clades, with clade-II TGAs (TGA2, TGA5, TGA6) functioning in systemic acquired resistance while TGA1/TGA4 have partially distinct roles .

Co-immunoprecipitation with TGA1 antibody followed by immunoblotting for other TGA factors can reveal heterodimerization patterns, an important regulatory mechanism for bZIP transcription factors like TGAs. To study competitive or cooperative binding to shared DNA targets, sequential ChIP (re-ChIP) can determine whether different TGA factors simultaneously occupy the same genomic regions. For dynamic studies of TGA factor recruitment during immune responses, ChIP time-course experiments with specific antibodies against different TGA factors can reveal sequential binding patterns, providing insights into their coordinated functions.

What does experimental data reveal about TGA1 expression patterns and regulation?

Experimental data provides several insights into TGA1 expression patterns and regulation. According to RT-qPCR analysis, there is no statistical difference in message accumulation between maize and teosinte alleles of tga1 (ANOVA: P = 0.9467), suggesting that phenotypic differences between these plants are not due to transcriptional regulation of TGA1 . This finding highlights the importance of post-transcriptional and post-translational regulation of TGA1, making antibody-based protein studies particularly valuable for understanding functional differences.

The data also indicates potential regulatory relationships between TGA1 and other genes. For instance, research has shown that the not1 message level is affected by TGA1 alleles, being lowest when there are maize alleles at both not1 and tga1, highest with teosinte alleles at both genes, and intermediate for heteroallelic genotypes . This suggests that maize-TGA1 represses not1 expression compared to teosinte-TGA1, revealing a regulatory function of TGA1 that appears to be altered during crop domestication.

Regarding TGA1's role in plant immunity, studies have identified 584 SA-induced NPR1-dependent genes that are independent from TGA1/TGA4 and 45 SA-induced NPR1-dependent genes that are regulated by TGA1/TGA4 . Interestingly, basal levels of these 45 genes, including PR1, were up-regulated in tga1 tga4 double mutants, suggesting that oxidized TGA1/TGA4, which has low DNA binding activity at least in vitro, may repress these genes . These findings indicate complex regulatory dynamics where TGA1 functions can be activating or repressing depending on context and potential post-translational modifications.

What are the current findings regarding TGA1's redox regulation and its functional significance?

Studies have shown that oxidized TGA1, which has low DNA binding activity in vitro, may actually repress certain genes, as evidenced by the up-regulation of 45 SA-induced NPR1-dependent genes in tga1 tga4 double mutants . This suggests a more complex model where TGA1 can function as both an activator and repressor depending on context. Additionally, research has identified NPR1-independent defense mechanisms involving TGA1, as demonstrated by the higher susceptibility of npr1 tga1 tga4 mutants compared to either npr1 or tga1 tga4 mutants alone .

These findings necessitate a reevaluation of how we interpret antibody-based studies of TGA1. Changes in signal intensity might reflect altered epitope accessibility due to conformational changes rather than actual protein level differences. Therefore, researchers should employ multiple antibodies recognizing different epitopes and conduct experiments under both reducing and non-reducing conditions to distinguish between these possibilities.

What have validation studies revealed about TGA1 antibody specificity and reliability?

For developability assessment of antibodies in general, research has established approaches including short-term stability studies at various temperatures (2−8°C, 25°C, and 40°C), freeze-thaw studies, limited forced degradation studies, and determination of viscosity for high concentration samples . These principles are applicable to TGA1 antibody evaluation, particularly for assessing stability and performance consistency across experiments.

The importance of proper validation is highlighted by the close relationship between TGA family members. The TGA family consists of ten members grouped into five clades , creating potential for cross-reactivity. Additionally, TGA1's redox-sensitive nature presents unique validation challenges, as epitope accessibility may vary with redox conditions . Researchers working with TGA1 antibody should therefore conduct comprehensive validation including:

• Specificity testing against recombinant TGA family proteins

• Validation in tga1 knockout/knockdown plants

• Peptide competition assays

• Performance assessment under varying redox conditions

• Batch-to-batch consistency evaluation

These validation approaches ensure reliable interpretation of results and minimize technical artifacts in TGA1 research.

What emerging technologies might enhance TGA1 antibody-based research?

Several emerging technologies hold promise for advancing TGA1 antibody-based research. Single-cell proteomics combined with TGA1 antibody detection could reveal cell-type-specific regulation patterns within complex tissues, providing unprecedented resolution of TGA1 function during development and immune responses. This approach would be particularly valuable for understanding the spatiotemporal dynamics of TGA1 activity that may be masked in whole-tissue analyses.

Proximity labeling techniques using TGA1 antibody fragments fused to enzymes like TurboID or APEX2 could enable in vivo identification of transient interaction partners and proximal proteins. This approach could help resolve the complex regulatory networks involving TGA1, particularly in the context of NPR1-dependent and independent pathways identified in previous research .

Super-resolution microscopy combined with TGA1 antibody immunolocalization could provide nanoscale insights into TGA1 nuclear organization, potentially revealing functional clustering within the nucleus during gene regulation. Multiplex immunoassays would allow simultaneous detection of TGA1 and other transcription factors or signaling components, facilitating comprehensive analysis of regulatory networks.

Mass cytometry (CyTOF) with metal-conjugated TGA1 antibodies could enable high-dimensional analysis of TGA1 in relation to multiple cellular parameters simultaneously. Computational approaches integrating antibody-derived data with other omics datasets would enhance systems-level understanding of TGA1 function. These technologies would be particularly valuable for addressing the complex redox regulation of TGA1 and resolving conflicting data regarding its function in plant immunity .

What knowledge gaps remain in TGA1 research that could be addressed using antibody-based approaches?

Several significant knowledge gaps in TGA1 research could be addressed using antibody-based approaches. First, the comprehensive map of TGA1 post-translational modifications beyond redox changes remains incomplete. While redox-active cysteines have been studied extensively , other modifications like phosphorylation, SUMOylation, and ubiquitination that may regulate TGA1 function are poorly characterized. Immunoprecipitation with TGA1 antibody followed by mass spectrometry analysis could identify these modifications and their dynamics during immune responses.

The cell-type-specific expression and function of TGA1 represents another knowledge gap. Most studies analyze whole tissues, potentially masking important spatial patterns. Immunohistochemistry with TGA1 antibody could reveal tissue and cell-type-specific expression patterns, while fluorescence-activated cell sorting (FACS) of specific cell types followed by TGA1 immunoblotting could quantify cell-type-specific expression levels.

The temporal dynamics of TGA1 chromatin binding during immune responses remain poorly understood. ChIP-seq time course experiments with TGA1 antibody following immune elicitation could map the kinetics of TGA1 recruitment to target promoters, helping to resolve its role in the 45 SA-induced NPR1-dependent genes identified in previous research .

How can integrative approaches combining antibody techniques with other methods advance TGA1 research?

Integrative approaches combining antibody techniques with complementary methods hold great promise for advancing TGA1 research. ChIP-seq with TGA1 antibody integrated with RNA-seq data can establish direct links between TGA1 binding events and transcriptional outcomes, helping resolve its complex role in gene regulation. This approach would be particularly valuable for understanding the 45 SA-induced NPR1-dependent genes regulated by TGA1/TGA4 identified in previous research .

Combining TGA1 antibody immunoprecipitation with mass spectrometry-based proteomics and phosphoproteomics can identify both interaction partners and post-translational modifications under different conditions. This integrated approach could help clarify the functional significance of TGA1's redox regulation, which has been questioned by recent research showing similar activity between wild-type TGA1 and a quadruple cysteine mutant that mimics the reduced form .

CRISPR-based genome editing to introduce epitope tags at the endogenous TGA1 locus, followed by standardized antibody detection of these tags, offers a powerful approach for comparing TGA1 behavior across mutant backgrounds and conditions. This strategy avoids potential artifacts from overexpression while enabling consistent detection.

Structural biology approaches such as cryo-electron microscopy using TGA1 antibodies to stabilize specific conformations could provide insights into how redox changes affect TGA1 structure. Single-molecule tracking of fluorescently labeled antibody fragments in living cells could reveal the dynamics of TGA1 nuclear localization and mobility during immune responses.

Finally, systems biology approaches integrating antibody-derived data on TGA1 protein levels, modifications, interactions, and genomic binding with transcriptomic, metabolomic, and phenomic datasets would provide comprehensive understanding of TGA1 function in the broader context of plant immunity and development. This integrative framework would help reconcile conflicting observations and build more accurate models of TGA1 function.